200 related articles for article (PubMed ID: 18044981)
21. LRP5 mutations in osteoporosis-pseudoglioma syndrome and high-bone-mass disorders.
Levasseur R; Lacombe D; de Vernejoul MC
Joint Bone Spine; 2005 May; 72(3):207-14. PubMed ID: 15850991
[TBL] [Abstract][Full Text] [Related]
22. Interaction between LRP5 and Frat1 mediates the activation of the Wnt canonical pathway.
Hay E; Faucheu C; Suc-Royer I; Touitou R; Stiot V; Vayssière B; Baron R; Roman-Roman S; Rawadi G
J Biol Chem; 2005 Apr; 280(14):13616-23. PubMed ID: 15699046
[TBL] [Abstract][Full Text] [Related]
23. Very low density lipoprotein receptor, a negative regulator of the wnt signaling pathway and choroidal neovascularization.
Chen Y; Hu Y; Lu K; Flannery JG; Ma JX
J Biol Chem; 2007 Nov; 282(47):34420-8. PubMed ID: 17890782
[TBL] [Abstract][Full Text] [Related]
24. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
Benhaj K; Akcali KC; Ozturk M
Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
[TBL] [Abstract][Full Text] [Related]
25. Expression of LDL receptor-related protein 5 (LRP5) as a novel marker for disease progression in high-grade osteosarcoma.
Hoang BH; Kubo T; Healey JH; Sowers R; Mazza B; Yang R; Huvos AG; Meyers PA; Gorlick R
Int J Cancer; 2004 Mar; 109(1):106-11. PubMed ID: 14735475
[TBL] [Abstract][Full Text] [Related]
26. Modulation of β-catenin signaling by glucagon receptor activation.
Ke J; Zhang C; Harikumar KG; Zylstra-Diegel CR; Wang L; Mowry LE; Miller LJ; Williams BO; Xu HE
PLoS One; 2012; 7(3):e33676. PubMed ID: 22438981
[TBL] [Abstract][Full Text] [Related]
27. Lrp5/β-Catenin Signaling Controls Lung Macrophage Differentiation and Inhibits Resolution of Fibrosis.
Sennello JA; Misharin AV; Flozak AS; Berdnikovs S; Cheresh P; Varga J; Kamp DW; Budinger GR; Gottardi CJ; Lam AP
Am J Respir Cell Mol Biol; 2017 Feb; 56(2):191-201. PubMed ID: 27668462
[TBL] [Abstract][Full Text] [Related]
28. Verification of predicted alternatively spliced Wnt genes reveals two new splice variants (CTNNB1 and LRP5) and altered Axin-1 expression during tumour progression.
Pospisil H; Herrmann A; Butherus K; Pirson S; Reich JG; Kemmner W
BMC Genomics; 2006 Jun; 7():148. PubMed ID: 16772034
[TBL] [Abstract][Full Text] [Related]
29. Influence of Calcium Supplementation against Fluoride-Mediated Osteoblast Impairment in Vitro: Involvement of the Canonical Wnt/β-Catenin Signaling Pathway.
Wang J; Yang J; Cheng X; Yin F; Zhao Y; Zhu Y; Yan Z; Khodaei F; Ommati MM; Manthari RK; Wang J
J Agric Food Chem; 2019 Sep; 67(37):10285-10295. PubMed ID: 31443611
[TBL] [Abstract][Full Text] [Related]
30. Caprin-2 enhances canonical Wnt signaling through regulating LRP5/6 phosphorylation.
Ding Y; Xi Y; Chen T; Wang JY; Tao DL; Wu ZL; Li YP; Li C; Zeng R; Li L
J Cell Biol; 2008 Sep; 182(5):865-72. PubMed ID: 18762581
[TBL] [Abstract][Full Text] [Related]
31. Curcumin-induced suppression of adipogenic differentiation is accompanied by activation of Wnt/beta-catenin signaling.
Ahn J; Lee H; Kim S; Ha T
Am J Physiol Cell Physiol; 2010 Jun; 298(6):C1510-6. PubMed ID: 20357182
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of LRP5/6-mediated Wnt/β-catenin signaling by Mesd attenuates hyperoxia-induced pulmonary hypertension in neonatal rats.
Alapati D; Rong M; Chen S; Lin C; Li Y; Wu S
Pediatr Res; 2013 Jun; 73(6):719-25. PubMed ID: 23481549
[TBL] [Abstract][Full Text] [Related]
33. In vitro effect of microRNA-107 targeting Dkk-1 by regulation of Wnt/β-catenin signaling pathway in osteosarcoma.
Zhang ZC; Liu JX; Shao ZW; Pu FF; Wang BC; Wu Q; Zhang YK; Zeng XL; Guo XD; Yang SH; He TC
Medicine (Baltimore); 2017 Jul; 96(27):e7245. PubMed ID: 28682874
[TBL] [Abstract][Full Text] [Related]
34. Truncated mutants of the putative Wnt receptor LRP6/Arrow can stabilize beta-catenin independently of Frizzled proteins.
Brennan K; Gonzalez-Sancho JM; Castelo-Soccio LA; Howe LR; Brown AM
Oncogene; 2004 Jun; 23(28):4873-84. PubMed ID: 15064719
[TBL] [Abstract][Full Text] [Related]
35. Normal hematopoiesis and lack of β-catenin activation in osteoblasts of patients and mice harboring Lrp5 gain-of-function mutations.
Galán-Díez M; Isa A; Ponzetti M; Nielsen MF; Kassem M; Kousteni S
Biochim Biophys Acta; 2016 Mar; 1863(3):490-498. PubMed ID: 26681532
[TBL] [Abstract][Full Text] [Related]
36. β-Catenin-dependent pathway activation by both promiscuous "canonical" WNT3a-, and specific "noncanonical" WNT4- and WNT5a-FZD receptor combinations with strong differences in LRP5 and LRP6 dependency.
Ring L; Neth P; Weber C; Steffens S; Faussner A
Cell Signal; 2014 Feb; 26(2):260-7. PubMed ID: 24269653
[TBL] [Abstract][Full Text] [Related]
37. Hypermethylated in cancer 1 (HIC1), a tumor suppressor gene epigenetically deregulated in hyperparathyroid tumors by histone H3 lysine modification.
Svedlund J; Koskinen Edblom S; Marquez VE; Åkerström G; Björklund P; Westin G
J Clin Endocrinol Metab; 2012 Jul; 97(7):E1307-15. PubMed ID: 22544915
[TBL] [Abstract][Full Text] [Related]
38. Suppression of Membranous LRP5 Recycling, Wnt/β-Catenin Signaling, and Colon Carcinogenesis by 15-LOX-1 Peroxidation of Linoleic Acid in PI3P.
Liu F; Zuo X; Liu Y; Deguchi Y; Moussalli MJ; Chen W; Yang P; Wei B; Tan L; Lorenzi PL; Gao S; Jaoude JC; Mehdizadeh A; Valentin LA; Wei D; Shureiqi I
Cell Rep; 2020 Aug; 32(7):108049. PubMed ID: 32814052
[TBL] [Abstract][Full Text] [Related]
39. Atorvastatin inhibits hypercholesterolemia-induced calcification in the aortic valves via the Lrp5 receptor pathway.
Rajamannan NM; Subramaniam M; Caira F; Stock SR; Spelsberg TC
Circulation; 2005 Aug; 112(9 Suppl):I229-34. PubMed ID: 16159822
[TBL] [Abstract][Full Text] [Related]
40. Absence of stabilizing mutations of beta-catenin encoded by CTNNB1 exon 3 in a large series of sporadic parathyroid adenomas.
Costa-Guda J; Arnold A
J Clin Endocrinol Metab; 2007 Apr; 92(4):1564-6. PubMed ID: 17284619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
